Trials / Unknown
UnknownNCT03195309
A Comparison of Different Concentration Ropivacaine for Patient-controlled Epidural Analgesia
A Comparison of Different Concentration Ropivacaine Combination With Fentanyl for Patient-controlled Epidural Analgesia After Cesarean Delivery
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To compare the postoperative analgesic effect and the intensity of motor block in different concentration ropivacaine plus fentanyl when used epidurally with a patient-controlled analgesia device after Cesarean delivery.
Detailed description
1. Written informed consent must be obtained before any study specific procedures are undertaken. 2. All patients were received epidural anesthesia with 2% Lidocaine and patient-controlled epidural analgesia (PCEA) for post- operative pain control. PCEA randomly allocated into three groups. Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl, Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl, and Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl. Dermographic data, dosage of PCEA during first 48 hours post-operation,NRS scores, patient satisfaction and the intensity of motor block will be recorded and analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Compare different concentration of ropivacaine and fentanyl for elective Cesarean delivery post operative pain control. |
| DRUG | Fentanyl | Compare different concentration of ropivacaine and fentanyl for elective Cesarean delivery post operative pain control. |
Timeline
- Start date
- 2017-01-20
- Primary completion
- 2018-12-01
- Completion
- 2019-06-01
- First posted
- 2017-06-22
- Last updated
- 2017-06-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03195309. Inclusion in this directory is not an endorsement.